MA47467A - Compositions phytothérapeutiques d'eschscholzia california et méthode pour le traitement de troubles du sommeil et oniriques - Google Patents
Compositions phytothérapeutiques d'eschscholzia california et méthode pour le traitement de troubles du sommeil et oniriquesInfo
- Publication number
- MA47467A MA47467A MA047467A MA47467A MA47467A MA 47467 A MA47467 A MA 47467A MA 047467 A MA047467 A MA 047467A MA 47467 A MA47467 A MA 47467A MA 47467 A MA47467 A MA 47467A
- Authority
- MA
- Morocco
- Prior art keywords
- eschscholzia
- dream
- california
- sleep
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Alternative & Traditional Medicine (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762458230P | 2017-02-13 | 2017-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47467A true MA47467A (fr) | 2019-12-18 |
Family
ID=63106880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047467A MA47467A (fr) | 2017-02-13 | 2018-02-13 | Compositions phytothérapeutiques d'eschscholzia california et méthode pour le traitement de troubles du sommeil et oniriques |
Country Status (9)
Country | Link |
---|---|
US (1) | US20200030399A1 (fr) |
EP (1) | EP3579835A4 (fr) |
JP (1) | JP2020507630A (fr) |
KR (1) | KR20190122707A (fr) |
CN (1) | CN110461331A (fr) |
CA (1) | CA3053422A1 (fr) |
MA (1) | MA47467A (fr) |
MX (1) | MX2019009676A (fr) |
WO (1) | WO2018145216A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3125706B1 (fr) * | 2021-07-29 | 2024-05-03 | Urgo Rech Innovation Et Developpement | Produit de combinaison pour stimuler le fonctionnement des cellules hépatiques et faciliter l’endormissement |
-
2018
- 2018-02-13 CA CA3053422A patent/CA3053422A1/fr not_active Abandoned
- 2018-02-13 CN CN201880020699.4A patent/CN110461331A/zh active Pending
- 2018-02-13 US US16/485,634 patent/US20200030399A1/en not_active Abandoned
- 2018-02-13 EP EP18750705.8A patent/EP3579835A4/fr not_active Withdrawn
- 2018-02-13 MA MA047467A patent/MA47467A/fr unknown
- 2018-02-13 JP JP2019564567A patent/JP2020507630A/ja active Pending
- 2018-02-13 WO PCT/CA2018/050161 patent/WO2018145216A1/fr active Application Filing
- 2018-02-13 MX MX2019009676A patent/MX2019009676A/es unknown
- 2018-02-13 KR KR1020197026391A patent/KR20190122707A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
MX2019009676A (es) | 2019-11-21 |
JP2020507630A (ja) | 2020-03-12 |
WO2018145216A1 (fr) | 2018-08-16 |
EP3579835A4 (fr) | 2020-08-19 |
US20200030399A1 (en) | 2020-01-30 |
CA3053422A1 (fr) | 2018-08-16 |
EP3579835A1 (fr) | 2019-12-18 |
KR20190122707A (ko) | 2019-10-30 |
CN110461331A (zh) | 2019-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49069A (fr) | Procédés et compositions pour le traitement d'apnée du sommeil | |
MA51200A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies | |
DK3731772T3 (da) | Systems for the treatment of disease states and disorders | |
MA50763A (fr) | Compositions d'acides aminés et méthodés de traitement de maladies et troubles musculaires | |
MA45798A (fr) | Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers | |
MA49279A (fr) | Compositions d'anticorps optimisées pour le traitement de troubles oculaires | |
DK3405215T3 (da) | Fremgangsmåder til behandling af danon-sygdom og andre autofagilidelser | |
MA51056A (fr) | Compositions et méthodes pour le traitement d'affections métaboliques | |
IL279161A (en) | Active substances and methods of their use for the treatment of metabolic disorders and non-alcoholic fatty liver disease | |
MA44886A (fr) | Compositions et méthode pour traiter des troubles acide-base | |
MA44737A (fr) | Compositions pour le traitement de troubles liés à l'hyperkératose | |
MA44126A (fr) | Méthodes de traitement de maladies et troubles pulmonaires | |
MA52631A (fr) | Compositions et méthodes pour le traitement de la maladie de parkinson | |
FR3032353B1 (fr) | Composition pharmaceutique et dispositif pour le traitement de la douleur | |
MA47069A (fr) | Formes pharmaceutiques contenant des inhibiteurs des canaux task-1 et task-3 et leur utilisation pour le traitement de troubles respiratoires | |
MA44426B1 (fr) | Compositions et méthodes pour diminier l'expression de tau | |
MA47503A (fr) | Composés et méthodes pour le traitement de maladies inflammatoires chroniques de l'intestin avec manifestations extra-intestinales | |
MA47074A (fr) | Formes pharmaceutiques comprenant des inhibiteurs de canaux de task-1 et task-3 et leur utilisation pour le traitement des troubles respiratoires | |
MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
MA50391A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de troubles inflammatoires | |
MA53741A (fr) | Procédés de traitement de troubles myéloprolifératifs | |
MA43825A (fr) | Schémas posologiques pour le traitement d'infections fongiques | |
FR3000896B1 (fr) | Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil | |
FR3020951B1 (fr) | Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique. | |
MA49794A (fr) | Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire |